Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-005
mi
from
Layton, UT
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-005
mi
from
Layton, UT
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research
mi
from
Salt Lake City, UT
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-093
mi
from
Falls Church, VA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-093
mi
from
Falls Church, VA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-085
mi
from
Manassas, VA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-085
mi
from
Manassas, VA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-094
mi
from
Midlothian, VA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-094
mi
from
Midlothian, VA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-023
mi
from
Richmond, VA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-023
mi
from
Richmond, VA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-029
mi
from
Suffolk, VA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-029
mi
from
Suffolk, VA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-114
mi
from
Tacoma, WA
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-114
mi
from
Tacoma, WA
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 1057
mi
from
Boca Raton, FL
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 1057
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-055
mi
from
Raritan, NJ
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-055
mi
from
Raritan, NJ
Click here to add this to my saved trials
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated:  12/31/1969
Research Site 10001-106
mi
from
Powell, TX
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Status: Enrolling
Updated: 12/31/1969
Research Site 10001-106
mi
from
Powell, TX
Click here to add this to my saved trials
Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease
Quantitative Myocardial Perfusion, Myocardial Scarring and Their Contribution to Late Clinical Decompensation in Adults With Congenital Heart Disease
Status: Enrolling
Updated:  12/31/1969
Children's National Health System
mi
from
Washington,
Myocardial Perfusion and Scarring in Adults With Congenital Heart Disease
Quantitative Myocardial Perfusion, Myocardial Scarring and Their Contribution to Late Clinical Decompensation in Adults With Congenital Heart Disease
Status: Enrolling
Updated: 12/31/1969
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries: Correlations With Non-invasive Coronary Computer Tomographic Angiography. (LUNAR-CCTA Study)
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries: Correlations With Non-invasive Coronary Computer Tomographic Angiography. (LUNAR-CCTA Study)
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
The Effect of Spice Consumption on Postprandial Vascular Function
The Effect of Chronic Consumption of Popular Spices on Postprandial Vascular Function
Status: Enrolling
Updated:  12/31/1969
Penn State University
mi
from
University Park, PA
The Effect of Spice Consumption on Postprandial Vascular Function
The Effect of Chronic Consumption of Popular Spices on Postprandial Vascular Function
Status: Enrolling
Updated: 12/31/1969
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Evaluation of a Novel Patient Warming System During MRI
Evaluation of a Novel Patient Warming System During MRI
Status: Enrolling
Updated:  12/31/1969
Children's National Health System
mi
from
Washington,
Evaluation of a Novel Patient Warming System During MRI
Evaluation of a Novel Patient Warming System During MRI
Status: Enrolling
Updated: 12/31/1969
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
A Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
A Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Red Blood Cell ATP Release and Vascular Function in Humans
Red Blood Cell ATP Release and Vascular Function in Humans
Status: Enrolling
Updated:  12/31/1969
Colorado State University, Dept. of Health and Exercise Science
mi
from
Fort Collins, CO
Red Blood Cell ATP Release and Vascular Function in Humans
Red Blood Cell ATP Release and Vascular Function in Humans
Status: Enrolling
Updated: 12/31/1969
Colorado State University, Dept. of Health and Exercise Science
mi
from
Fort Collins, CO
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
University of Florida (UF) Jacksonville
mi
from
Jacksonville, FL
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
University of Florida (UF) Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine - Krannert Institute of Cardiology
mi
from
Indianapolis, IN
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine - Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Inova Center For Thrombosis Research and Translational Medic
mi
from
Falls Church, VA
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Inova Center For Thrombosis Research and Translational Medic
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Tampa - Pepin Heart Institute
mi
from
Tampa, FL
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Tampa - Pepin Heart Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
NorthShore University
mi
from
Chicago, IL
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
NorthShore University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Inova Cardiology
mi
from
Lutherville, MD
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Inova Cardiology
mi
from
Lutherville, MD
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital New York
mi
from
New York, NY
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital New York
mi
from
New York, NY
Click here to add this to my saved trials
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Institut de Cardiologie de Montréal
mi
from
Montréal,
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
A Multi-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Pharmacodynamics, Pharmacokinetics, Tolerability, and Safety of a Single Subcutaneous Injection of ACT-246475 in Adults With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Institut de Cardiologie de Montréal
mi
from
Montréal,
Click here to add this to my saved trials
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease (smartGUIDE)
Status: Enrolling
Updated:  12/31/1969
Stanford HealthCare
mi
from
Stanford, CA
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease
Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease (smartGUIDE)
Status: Enrolling
Updated: 12/31/1969
Stanford HealthCare
mi
from
Stanford, CA
Click here to add this to my saved trials
CREATION Health Lifestyle Intervention
CREATION Health Lifestyle Intervention
Status: Enrolling
Updated:  12/31/1969
Florida Hospital
mi
from
Orlando, FL
CREATION Health Lifestyle Intervention
CREATION Health Lifestyle Intervention
Status: Enrolling
Updated: 12/31/1969
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Stress Reduction Intervention for Women With Ischemic Heart Disease
Smartphone-delivered Stress Reduction Intervention for Women With Ischemic Heart Disease
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Stress Reduction Intervention for Women With Ischemic Heart Disease
Smartphone-delivered Stress Reduction Intervention for Women With Ischemic Heart Disease
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Integrating Pharmacogenetics In Clinical Care
Clinical Safety and Efficacy of Pharmacogenetics in Veteran Care
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Integrating Pharmacogenetics In Clinical Care
Clinical Safety and Efficacy of Pharmacogenetics in Veteran Care
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat PAD
Feasibility Clinical Trial of the Cardio ?Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Research of North Florida
mi
from
Gainesville, FL
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat PAD
Feasibility Clinical Trial of the Cardio ?Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Research of North Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat PAD
Feasibility Clinical Trial of the Cardio ?Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated:  12/31/1969
Eastlake Cardiovascular, PC
mi
from
Saint Clair Shores, MI
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat PAD
Feasibility Clinical Trial of the Cardio ?Flow FreedomFlow Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Eastlake Cardiovascular, PC
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins ProHealth Clinical Research Center
mi
from
Baltimore, MD
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins ProHealth Clinical Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated:  12/31/1969
Wake Forest Sticht Center on Aging
mi
from
Winston-Salem, NC
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated: 12/31/1969
Wake Forest Sticht Center on Aging
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated:  12/31/1969
Julius Clinical
mi
from
Zeist,
Moderate Alcohol and Cardiovascular Health Trial
Moderate Alcohol and Cardiovascular Health Trial
Status: Enrolling
Updated: 12/31/1969
Julius Clinical
mi
from
Zeist,
Click here to add this to my saved trials
Improving Neurodevelopment in Adolescents With Congenital Heart Disease
Pilot Study of Executive Function Intervention to Improve Neurodevelopmental Outcomes in Adolescents With CHD
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Improving Neurodevelopment in Adolescents With Congenital Heart Disease
Pilot Study of Executive Function Intervention to Improve Neurodevelopmental Outcomes in Adolescents With CHD
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease
A Partnership to Translate an Evidence-based Intervention for Vulnerable Older Adults With Heart Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan School of Public Health
mi
from
Ann Arbor, MI
A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease
A Partnership to Translate an Evidence-based Intervention for Vulnerable Older Adults With Heart Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan School of Public Health
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Physical Activity and Pacemaker Study
Reducing Sedentary Time in Individuals With Pacemakers - Tracking By Pacemaker-Based Accelerometry
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin/Froedtert Memorial and Lutheran Hospital
mi
from
Milwaukee, WI
Physical Activity and Pacemaker Study
Reducing Sedentary Time in Individuals With Pacemakers - Tracking By Pacemaker-Based Accelerometry
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin/Froedtert Memorial and Lutheran Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oatmeal Effect on N-acyl-phosphatidylethanoleamines
Acute Effects of Dietary Oatmeal on Serum Levels of N-acyl-phosphatidylethanoleamines and Their Metabolites.
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Oatmeal Effect on N-acyl-phosphatidylethanoleamines
Acute Effects of Dietary Oatmeal on Serum Levels of N-acyl-phosphatidylethanoleamines and Their Metabolites.
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
BerryCare: A Community Engagement Program
BerryCare: A Blackberry Extension Lesson Series to Facilitate Community Engagement and Phytonutrient Intake
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
BerryCare: A Community Engagement Program
BerryCare: A Blackberry Extension Lesson Series to Facilitate Community Engagement and Phytonutrient Intake
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
An Open-Label, Randomized, Three-Treatment, Three-Way Crossover Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
An Open-Label, Randomized, Three-Treatment, Three-Way Crossover Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Bio-Kinetic Clinical Applications, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function Genotype: a Validation Study in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Jacksonville, FL
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function Genotype: a Validation Study in Patients With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Comparison of Canagliflozin vs. Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Patients With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Janssen Investigative Site
mi
from
Titusville, NJ
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Comparison of Canagliflozin vs. Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Patients With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Janssen Investigative Site
mi
from
Titusville, NJ
Click here to add this to my saved trials
The Effect of Potatoes on Markers of Cardiometabolic Health
The Effect of Potatoes on Markers of Cardiometabolic Health
Status: Enrolling
Updated:  12/31/1969
Pennsylvania State University
mi
from
University Park, PA
The Effect of Potatoes on Markers of Cardiometabolic Health
The Effect of Potatoes on Markers of Cardiometabolic Health
Status: Enrolling
Updated: 12/31/1969
Pennsylvania State University
mi
from
University Park, PA
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
Orlando Health
mi
from
Orlando, FL
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
Orlando Health
mi
from
Orlando, FL
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
Prairie Heart
mi
from
Springfield, IL
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
Prairie Heart
mi
from
Springfield, IL
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
Cox Health
mi
from
Springfield, MO
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
Cox Health
mi
from
Springfield, MO
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
Rex Healthcare
mi
from
Raleigh, NC
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
Rex Healthcare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated:  12/31/1969
The Hospitals of Providence
mi
from
El Paso, TX
Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"
Peripheral Registry of Endovascular Clinical Outcomes
Status: Enrolling
Updated: 12/31/1969
The Hospitals of Providence
mi
from
El Paso, TX
Click here to add this to my saved trials
Ischemic Preconditioning Claudication Study
Walking Capacity of Patients With Claudication in Lower Extremities Following Ischemic Preconditioning
Status: Enrolling
Updated:  12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Ischemic Preconditioning Claudication Study
Walking Capacity of Patients With Claudication in Lower Extremities Following Ischemic Preconditioning
Status: Enrolling
Updated: 12/31/1969
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials